Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors with high prevalence
among adult populations and elevated costs for public health systems worldwide. Despite …

Many approaches have been used in the effective management of type 2 diabetes mellitus.
A recent paradigm shift has focused on the role of adipose tissues in the development and …

Background The epidemiology of COVID-19 and its association with cardiometabolic
disorders is poorly understood. This is a narrative review that investigates the effects of …

The prevalence of the metabolic syndrome, a cluster of cardiovascular risk factors
associated with obesity and insulin resistance, is dramatically increasing in Western and …

Background Obesity accompanied by excess ectopic fat storage has been postulated as a
risk factor for severe disease in people with SARS‐CoV‐2 through the stimulation of …

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors that includes obesity,
diabetes, and dyslipidemia. Accumulating evidence implies that MetS contributes to the …

The introduction of dual‐energy X‐ray absorptiometry (DXA) in the 1980s for the
assessment of areal bone mineral density (BMD) greatly benefited the field of bone imaging …

Being overweight or obese, as measured with body-mass index or central adiposity (waist
circumference), and the trajectory of body-mass index over the life course have been …

CONTEXT: Metabolic syndrome (MetS), a cluster of several metabolic abnormalities with a
high socioeconomic cost, is considered a worldwide epidemic. Recent epidemiologic and …

Metabolic syndrome is a cluster of cardiovascular risk factors including obesity, diabetes and
dyslipidemia. Insulin resistance (IR) is at the core of metabolic syndrome. In adipose tissue …